Enanta Pharmaceuticals Inc. buy BiotechBee
Start price
28.09.25
/
70%
€7.65
Target price
30.09.27
€10.00
Performance (%)
20.92%
End price
18.10.25
€9.25
Summary
This prediction ended on 18.10.25 with a price of €9.25. The prediction had a final performance of 20.92%. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Enanta Pharmaceuticals Inc. | -4.065% | -4.065% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
According to BiotechBee what are the pros and cons of Enanta Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Enanta Pharmaceuticals Inc. diskutieren
Buy mit Kursziel 10,0
In the thread Trading Enanta Pharmaceuticals Inc.
Buy beendet
Stopped prediction by BiotechBee for Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€10.30
16.09.24
16.09.24
€18.00
28.02.27
28.02.27
-41.26%
14.12.24
14.12.24
Could be very worthwhile Investment >20% year
Enanta Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€46.60
11.01.23
11.01.23
€60.00
31.12.25
31.12.25
-30.47%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year

